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Background: In addition to 51chromium release assay,
flow cytometric methods have been described to assess in
vitro cell-mediated cytotoxicity. In this report, we de-
scribe a new flow cytometric approach for determination
of in vitro cell-mediated cytotoxicity utilizing three-color
flow cytometric assay.
Methods: This method is based on monoclonal antibody
staining of either effector or target cells to evaluate cyto-
toxicity with increased accuracy by utilizing fluoro-
spheres for calibration. The basic strategy involves label-
ing effector or target cells with a specific fluorescent-
conjugated monoclonal antibody, in addition to staining
with annexinV-FITC and propidium iodide to identify ap-
optotic/dead cells. The effector and target cell popula-
tions as well as conjugates were clearly and easily identi-
fied by this approach.
Results: We obtained significant correlation between cy-
totoxicity calculated by this technique and 51chromium
release assay results. The integration of fluorospheres al-
lowed us to determine the absolute number of events
reflective of the cumulative cell death rather than a cross-
sectional, percentage-based cytotoxicity assessment in the
target cell population at the time of analysis.
Conclusions: This method provides additional advan-
tages to other methods and enables the study of target cell
fate in more detail, as well as providing a potential con-
tribution to understanding the mechanisms of cell elimi-
nation. Cytometry Part A 56A:53–60, 2003.
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51Cr release assay (CRA) has been the standard and most
popular method to study cell-mediated cytotoxicity in
vitro. In this method, target cells are loaded with Na51CrO,
which passively enters cells and binds to intracellular
proteins. Upon target cell lysis, 51Cr is released into the
supernatant and the amount of 51Cr is quantified using a
beta or a gamma counter. Though this method has the
benefits of being reproducible and relatively easy to per-
form, it has several drawbacks, including: the difficulty in
labeling cells with low cytoplasm–nucleus ratio; increas-
ing spontaneous release of 51Cr from target cells (15%)
over time, especially in long-term assays; a delay between
actual cell damage and release of 51Cr-bound intracellular
proteins into the supernatant; and the measurement of
cytolysis at the population versus single-cell level. Chro-
mium release assay reflects the changes in the entire target
cell population, i.e., partial 51Cr release from the entire
target population or total 51Cr release from a fraction of
the targets cells. Also there is need for specific care and
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handling associated with radioactive isotope usage, with
the high cost and the short half-life of the radioisotope
(1,2).
Nonradioactive methods, such as fluorescent labeling of
effector or target cell populations, have also been used.
Initially, these methods were used to measure increases in
target cell membrane permeability for the assessment of
cell-mediated cytotoxicity. Fluorescent dyes such as car-
boxy-fluorescein diacetate can be loaded into the cell
cytoplasm with relative ease. Upon cytolysis, the release
of these dyes into the supernatant or their retention in
target cells is measured using a microfluorimeter. How-
ever, spontaneous release of these dyes can be quite high,
giving rise to spurious results and limiting their use in
short-term assays. Alternately, two-color flow cytometry
has been used to measure increases in target-cell mem-
brane permeability. Target cells are labeled with a variety
of fluorescent reagents such as calcein-AM prior to the
cytolytic assay (3). Lysis is measured by two-color flow
cytometry as an increase in membrane permeability suffi-
cient to allow access of DNA-binding dyes to the target
cell nucleus. This approach has proven useful, especially
in the context of longer-term assays, in which use of CRA
is problematic because of leakage from target cells. There
has been a similar dye-leakage problem with cell mem-
brane binding fluorochromes, such as PKH-2, PKH-26, or
F-18, which has resulted in artifactual staining of other
populations during the coincubation (2). In recent years,
several groups have developed multicolor flow cytometry-
based methods using the dyes listed above, and others, to
study cell-mediated cytotoxicity (4–7).
An essential element of the multicolor flow cytometric
assays is the ability to discriminate effector cells from
target cells by further characterization of the target cell
fate. Several different methods have been suggested to
identify target and effector populations, such as the use of
differences in light scattering properties. Recently, Zamai
et al. (8) developed a flow cytometric assay using precul-
ture, direct staining, with a CD56-antibody and light scat-
ter changes for the detection of cytotoxicity against K-562
cells, which can be useful, although not easily adapted to
other systems (8,9). In later studies, researchers utilized
mAb staining in combination with either PI or annexinV-
FITC (AnnV) (2,8).
In this report, we describe a new approach for deter-
mination of in vitro cell-mediated cytotoxicity utilizing
three-color flow cytometric analysis. Our assay is based on
mAb staining of either effector or target cells to evaluate
cytotoxicity with increased accuracy by utilizing fluoro-
spheres (Flow-count™ fluorospheres, Beckman Coulter,
Miami, FL) for calibration. The basic strategy involves
labeling effector or target cells with specific fluoro-
chrome-conjugated mAbs, in addition to staining with
AnnV and PI to identify apoptotic/dead cells. Membrane
phosphatidylserine (PS) externalization occurs during ap-
optosis; AnnV binds to the externalized PS, providing a
convenient in vitro tool to measure apoptotic cell death.
Externalization of PS has been demonstrated to precede
changes in plasma membrane permeability as measured
by PI uptake (1,2). The addition of fluorospheres allowed
us to determine the absolute number of events reflective
of the cumulative cell death, rather than a cross-sectional,
percentage-based cytotoxicity assessment in the target
cell population at the time of analysis.
MATERIALS AND METHODS
Purification of Human Peripheral Blood
Lymphocytes and the Generation of Lymphokine-
Activated Killer (LAK) Cells
Fresh PBLs were isolated after centrifuging fresh blood
collected from healthy donors on Ficoll Histopaque-1077
(Sigma, St. Louis, MO). Fresh PBL were cultured for three
days at a concentration of 1  106 cells/ml in RPMI 1640
medium supplemented with 10% FBS, 2 mM glutamine, 50
g/ml gentamycin in the presence of IL-2 (50 U/ml) and
IL-15 (10 ng/ml) (Biosource, Camarillo, CA). Cells were
maintained in 25 cm2 flasks and kept in the incubator
(37°C, 5% CO2).
Target Cells
The human erythroleukemia cell line K-562 is known to
be NK-sensitive and has been used as the reference-stan-
dard cell line in cytotoxicity studies. Daudi is a malignant
B-lymphoblastoid cell line and is LAK-sensitive. In a num-
ber of experiments we also used MEG-01 and U-937 my-
eloid leukemia cell lines. These cell lines were obtained
from ATCC (Manassas, VA) and maintained in RPMI 1640
culture media, supplemented with 10% FBS. Before coin-
cubation, target and effector cell viability were deter-
mined by the trypan blue exclusion test; a viability of
90% was required to proceed.
Labeling Effector Cells and the Use of mAbs
We initially utilized three different T-cell/NK-cell–asso-
ciated mAbs: CD5-PE, CD7-PE, and CD2-PE, to mark the
effector population. We obtained a better separation of
the target cells from the effector population with CD2
staining in LAK cell samples. Both CD2 and CD7 are
expressed in a great majority of LAK populations and CD2
expression in LAK cells was greater than 85% and mostly
related to IL-2 induced upregulation (10). CD2 expression
in LAK cells has an important role related to cytotoxicity
in LAK cells (11). CD2 can also be used for marking fresh
PBL and it was easy to separate CD2-negative Daudi and
K-562 cells from CD2-positive effector cells. All monoclo-
nal antibodies were purchased from Immunotech, Inc.
(Westbrook, ME).
Marking Target Cells and mAbs
We utilized mAbs anti-CD33-PE for K-562 and anti-
CD19-PE for the Daudi cell lines. mAbs were purchased
from Immunotech, Inc. (Westbrook, ME).
Flow Cytometric Cell-Mediated Cytotoxicity Assay
(FCM-CMCA) Setup
We performed the following stepwise approach in pre-
paring and analyzing the samples:
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Effector and target cells were coincubated in certain ef-
fector/target (E/T) ratios. Effector and target cells were
added to 12  75 mm (5 mL) round bottom polystyrene
tubes (Falcon, (Becton-Dickinson, Franklin Lakes, NJ) in var-
ious E/T ratios (0.5:1, 1:1, 2:1, 4:1, 8:1, 16:1, up to 128:1) for
different incubation times. Control tubes including target or
effector cells alone were studied to determine the location of
populations on the histograms and spontaneous target cell
apoptosis. Tubes were centrifuged at 115 g for 5 min and
incubated at 37°C in 5% CO2 for 2, 4, and 18 h.
Then cells were incubated with 10 l of mouse anti-
human PE-conjugated mAb (either CD2, CD33, or CD19)
for 20 min at room temperature. In different experimental
settings, either target or effector cells were stained with
fluorescent-conjugated monoclonal antibodies.
To mark cell apoptosis/death, cells were incubated with
FITC-conjugated AnnV and PI (TACS™ AnnexinV-FITC; R&D
Systems, Minneapolis, MN) for 20 min before acquisition.
To determine the absolute number of viable or dead
target cells and to standardize the analysis, 20 l of Flow-
count™ fluorospheres were added to cell suspensions (50
l). Flow-count fluorospheres consist of 10 m (nominal
diameter) polystyrene fluorospheres in an aqueous sus-
pension medium containing a surfactant and 1% formal-
dehyde. Each fluorosphere contains a dye, which has a
fluorescence emission range of 525 nm to 700 nm when
excited at 488 nm. Fluorosphere count has been used as a
constant and independent means of halting data collection
during analysis and to standardize samples to obtain accu-
rate cell counts for T, B, NK lymphocyte, and lymphocyte
subsets in whole blood analysis using flow cytometry (12).
Since data acquisition time and sample flow rate varied
between the samples, target cell numbers, and fluoro-
sphere numbers, suspension volume, and the acquisition
time were held constant in target-alone and in coincuba-
tion tubes, with varying E/T ratios in every experiment.
Thus, data collection from each sample could be standard-
ized to acquire absolute cell counts. This enabled us to
calculate the number of targets left alive per unit volume
and to yield reliable intersample comparison. At least
1,000 fluorospheres were counted in each tube.
FCM Acquisition and Running
FCM was performed using an EPICS-XL MCL (multicar-
ousel) (Coulter, Miami, FL) equipped with an argon laser
(15 mW) source operating at 488 nm. The emission of
three fluorochromes was recorded through specific band
pass filters: 525 nm for FITC (FL1), 575 nm for PE (FL2),
620 nm for fluorospheres (FL3), and 675 nm for PI (FL4).
The instrument was set for four-color analysis. As the
emission spectra of the three different dyes and fluoro-
spheres utilized in this bioassay interfere with one an-
other, appropriate electronic compensations were ad-
justed by running individual cell populations stained with
each dye consecutively through the EPICS. Once the com-
pensations had been set, a gating was done on forward
scatter (FS) (ordinate) versus log-scale red fluorescence of
CD2 or other mAbs (abscissa), to separate target cells from
effector cells. The different cell populations were gated
with the use of control samples. To measure target-cell
death and apoptosis, CD2-negative (effector staining ap-
proach) and CD33- or CD19-positive events (target stain-
ing approach) were gated on, and analysis of log green
fluorescence (AnnV) versus log red fluorescence (PI) was
performed (Fig. 1a and b). FCM analysis lasted until a
minimum of 1,000 fluorospheres had been acquired in a
fixed acquisition time on each tube.
FCM-CMCA Data Analysis
An average of 10,000 total events and 3,000 target cells
were collected per sample. Data were reevaluated on list
mode analysis using Coulter System II™ Version 3 soft-
ware for the EPICS XL-MCL. The gating for the target cells
was based on the target-alone analysis and kept constant
throughout all tubes to avoid exaggeration of the counts
due to apoptotic body contamination. Cytotoxicity calcu-
lations were based on viable populations in target-alone
and coculture tube analysis results. Viable target-cell per-
centage and corresponding fluorosphere-adjusted counts
were determined, and calculations were based on the
control-tube values. We expressed the cell-mediated cyto-
toxicity in two different ways:
Percentage-Based (Cross-Sectional) Cytotoxicity
In this approach, we used the percent of AnnV-nega-
tive/PI-negative events (viable cell population) for the
target-cell gate in target-alone (control) and coculture
analysis, to correct for spontaneous apoptosis with the
following formula:
Percent Cytotoxicity (PC) 
[Control-viable cell percent]
 [Co-incubation-viable cell percent]
[Control-viable cell percent]
The result reflects the rate of cells undergoing apoptosis/
death (AnnV/PI– and AnnV/PI events) at the time of
sampling. Using the viable population helped us to ac-
count for all forms of cell death that occurred.
Cumulative Cytotoxicity
Instead of using percentages, we utilized corresponding
fluorosphere-adjusted counts in the same equation given
above. The result reflects the total cell loss that occurred
during the entire incubation period rather than the rate of
cell apoptosis/death at the time of sampling.
Cumulative Cytotoxicity (CC) 
[Fluorosphere-adjusted counts of control viable cells]
 [Fluorosphere-adjusted counts
of coincubation viable cells]
[Fluorosphere-adjusted counts of control viable cells]
51Cr-release Assay
A standard assay was performed as previously described
(13). Briefly, the assay is a standard 4-h 51Cr release assay
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using target cells that have been prelabeled with 100 Ci
51Cr (Perkin Elmer, Boston, MA) for 1 h. Prior to use in the
assay, the target cells were washed three times with me-
dium to remove excess 51Cr. Several concentrations of
PBL or LAK cells were added to a fixed number of target
cells (5,000) in a round-bottom microtiter plate to a total
volume of 0.2 ml. The plate was then centrifuged for 5
min at 1,000 rpm, after which the plate is incubated at
37°C for 4 h. Following the 4-h incubation, 0.1 ml of the
supernatant was carefully harvested and counted on a
scintillation counter (Packard, Downers Grove, IL). The
percentage of cytotoxicity was calculated using the fol-
lowing equation: (E – S)/(M – S)  100, where E is the
experimental counts per minute, S is the spontaneous
counts per minute and M is the maximum counts per
minute. Maximum release was determined from wells
FIG. 1. a: Identification of effector and target
cells in coincubations using target-ell labeling is
shown in histograms obtained from an experi-
ment where LAK cells were coincubated with
CD19-positive Daudi cells. Evaluation of the cell
populations gated by AnnV/PI staining is shown
in the rectilinear boxes in the bottom row of
histograms. In this representative sample, Daudi
cell viability decreased from 91% to 67% with
coincubation (E/T ratio: r2:1). The early apopto-
tic population increased from 4% to 8% as well as
the late apoptotic population, from 4% to 24%.
(E: effector area, T: target area, R2: late apopto-
tic/dead [AnnV/PI] population, R3: viable
[AnnV–/PI–] population, R4: early apoptotic
[AnnV/PI–] population.) b: The location of the
conjugate population using effector cell labeling
is shown in a coincubation histogram (E: effec-
tor, CD2 positive events; T: target, CD2 negative
events; C: conjugate area, CD2 positive events
those with larger sizes [higher FS values]). c:
Conjugate formation between K-562 and LAK
cells with W/G staining.
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including target cells and 10% sodium dodecyl sulfate
(SDS) in the medium. Spontaneous release was measured
from wells containing a fixed number of target cells in the
medium.
Cell Staining for Microscopy With Wright/Giemsa
At the end of the coincubation period, the sample was
gently mixed and 10 l was used to prepare slides at room
temperature without cytospinning. The slides were then
stained with Wright/Giemsa (W/G). A conjugate forma-
tion between K-562 and LAK cells with W/G staining is
demonstrated in Figure 1c.
Statistical Analysis
The correlation between PC and CC measured by flow
cytometer and the CRA results was studied using Pear-
son’s correlation analysis with the Statistical Package for
Social Sciences (SPSS-11.5 for Windows). Significance was
determined as  0.05.
RESULTS
Two leukemia/lymphoma cell lines, K-562 and Daudi,
were used as the main targets in this study to compare our
method with the standard CRA. K-562 is a NK-sensitive
cell line and has been used as a standard target cell in
cytotoxicity assays. However, Daudi is known to be NK-
activity—resistant, but LAK-sensitive. Because we have
shown that LAK activity reaches a peak level at three-day
incubation of PBL in culture with a combination of IL-2
and IL-15, we utilized fresh PBL and LAK cells obtained
following three-day culture as effectors (14). This cytokine
combination also produced more effective LAK activity
compared to other combinations such as PHAIL-2, anti-
CD3IL-2 and IL-15. We also evaluated the LAK cytotox-
icity of these three protocols by CRA in certain experi-
ments and saw a very good correlation between CRA and
our method.
Percentage-based cytotoxicity reached peak levels at
the end of 2–4 h of coincubation and started declining
after 4 h, depending on the target cell population (5,8,15).
In comparison studies with CRA, samples were coincu-
bated for 4 h, whereas in some experiments samples were
coincubated for 2 h (Fig. 2).
After studying several different E/T ratios in both cell
lines, we used a 2:1 ratio for many comparisons due to the
superior separation of the target and effector cell popula-
tions at this ratio. There was ratio-dependent cell kill as
shown in Figure 3. It has been reported that E/T ratios up
to 10:1 and 20:1 have been successfully used in flow
cytometric cell-mediated cytotoxicity assays (4).
Fresh PBL/NK Cytotoxicity Evaluation by FCM-
CMCA Using Effector Cell Labeling
Fresh PBL/NK cytotoxicity experiments using effector
cell labeling with CD2 were evaluated in a total of five
different experiments with a minimum of five different
E/T ratios each time, using K-562 and Daudi cells, and
results were compared with CRA. Consistent with the
literature, lower target-cell killing was observed compared
to the results obtained with LAK cells as effectors. In fresh
PBL studies, early apoptotic cells (AnnV/PI–) were more
pronounced than the late apoptotic/dead (AnnV/PI)
events. There was a positive correlation between PC and
CRA results in K-562- and Daudi-cell killing (r  0.94; P 
0.009 and r  0.95; P  0.007, respectively) (Fig. 4). Since
our calculation approach takes early apoptotic cells into
account, the PC and CC appeared to be higher than the
CRA results. In other words, early apoptotic cells may still
have their membrane integrity, preventing 51Cr release
consistent with the literature (5,16). Similarly, CRA results
correlated with FCM-CMCA when CC was calculated for
both cell lines (r  0.93; P  0.012 and r  0. 81; P 
FIG. 2. Kinetics of LAK cytotoxicity by PC in three different cell lines at
2:1 ratio at different coincubation times by effector cell labeling. The
mean PC reaches a maximum level at 2–4 h of coincubation in all myeloid
leukemia cell lines tested in three different sets of experiments.
FIG. 3. LAK cell cytotoxicity in representative samples of K-562 and
Daudi cell lines by target labeling at eight different ratios (r). Increasing
cytotoxicity with higher E/T ratios up to 8:1 by PC calculation was
observed in these studies. A superior LAK cell killing was observed in
Daudi cells than K-562 cells, reflective of the known enhanced sensitivity
of Daudi cells to LAK cells.
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0.04, respectively). As expected from the above results,
there was a statistically significant correlation between PC
and CC calculations for both cell lines (r  0.96; P 
0.004 and r  0.92; P  0.01, respectively).
LAK Cytotoxicity Evaluation by FCM-CMCA
Using Target Cell Labeling
LAK cytotoxicity was evaluated in six different experi-
ments with a minimum of five different E/T ratios each
time. CD33 labeling was used for K-562 cells and CD19 for
Daudi cells. PC and CRA results correlated very well for
both cell lines (r  0.97; P  0.007 and r  0.99; P 
0.007, respectively). There was also a positive correlation
between CC obtained from FCM-CMCA and CRA results
for both cell lines (r  0.98; P  0.003 and r  0.98; P 
0.02, respectively) (Fig. 5). Again, PC correlated signifi-
cantly with CC in both cell lines (r  0.90; P  0.040 and
r  0.96; P  0.044, respectively).
One of the advantages of our approach is to be able to
further characterize the fate of target cells in coincuba-
tion. Since PI cells represent either dead or late apopto-
tic cells, CRA results are expected to correlate better with
cytotoxicity analysis taking only these cells into account,
excluding AnnV/PI– events. As shown in Figure 6, CRA
results have correlated with PC calculations based on
viable target cell population (AnnV–/PI–) as described un-
der the methods section, as well as PC-PI calculations
based solely on dead/late apoptotic (PI) events (n  4;
r  1; P  0.002, and n  4; r  1; P  0.003, respec-
tively).
When we used our experimental data together (fresh
PBL and LAK) in comparing FCM-CMCA with CRA results,
there was a significant correlation for both PC (n  19;
r  0.95; P  0.001) and CC (n  19; r  0.77; P 
0.001).
Comparison of Simultaneous Target
and Effector Cell Labeling
In a total of seven different experiments, we compared
the reproducibility of the result using target-cell and ef-
fector-cell labeling with specific mAbs simultaneously.
K-562 and Daudi cells were incubated with either fresh
PBL or LAK cells. CD2 was used for effector-cell labeling,
and CD33 or CD19 were used for target cell labeling in
different coincubations, as stated above. Both PC and CC
correlated for these two different mAb-staining strategies
performed simultaneously in K-562 cells (r  0.86; P 
0.001, and r  0.92; P  0.001). A similar correlation was
observed for Daudi cells (r  0. 87; P  0.029, and r 
0.89; P  0.001).
FIG. 4. Fresh PBL/NK cytotoxicity evaluation by the FCM-CMCA
method (PC) and CRA in K-562 cells are compared. The values represent
mean killing of K-562 cells in three different sets of effector labeling
experiments and CRA. Since early apoptotic cells were included in PC
calculations, PC values were higher than CRA results.
FIG. 5. LAK cell cytotoxicity on Daudi by different FCM-CMCA calcu-
lation methods (PC and CC) and CRA. The results reflect mean values of
three different sets of experiments. Target cells were labeled with CD19
mAb.
FIG. 6. Comparison between CRA and FCM-CMCA analysis using differ-
ent PC calculation methods. LAK cell killing was evaluated using target
labeling in Daudi cells in this representative sample. There was a positive
correlation between CRA and PC calculated in two different ways, based
on either viability (PC) or late apoptotic/dead population (PC-PI) percent-
ages. The observed correlation may partially be secondary to the relatively
low percentages of early apoptotic cells at the time of analysis.
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Conjugate Evaluation
This assay can also be used to study the formation of
conjugates between effectors and targets (8). Since cell-
to-cell interaction is required for target-cell kill in the
cellular immune reaction, conjugate formation is a neces-
sary step in this process. However, the formation of con-
jugates may occur very early during the course of incuba-
tion, and detection may be difficult if samples are analyzed
after a certain time period (Fig. 1b and c). Conjugate
formation has been reported to reach a maximum after
40–60 min of coincubation when LAK cells are used as
effectors (9). It has also been shown that after 1 h of
culture with high E/T cell ratios, about one-third of the
dead targets were still conjugated to effectors. We have
observed different patterns of conjugate formation de-
pending on the target cell type and E/T ratio, as well as the
incubation time. This information can also be used in
kinetic analysis of cell-mediated cytotoxicity.
DISCUSSION
This is the first study to our knowledge to combine
effector- or target-cell staining using fluorescence-conju-
gated mAb with AnnV/PI colabeling to elucidate the fate
of target cells by FCM-CMCA. We also integrated the use of
fluorospheres to account for the entire target-cell loss
throughout coincubation, rather than determining the
cross-sectional assessment of the dynamic cell elimination
process at the time of sampling using PC calculations. This
approach appears to be reproducible, easy, and reliable
with very significant correlations obtained when com-
pared to CRA results.
The determination of target-cell death/apoptosis by
AnnV/PI or AnnV/7-AAD staining has been used with
PKH-26 and PKH-67 labeling, respectively (7,16). How-
ever, some investigators expressed concern about such
dyes leaking and labeling other cells in the environment
during coincubation (8). In a limited number of experi-
ments in which we utilized such dyes, we also faced the
same difficulties. Moreover, in studies where target-cell
labeling with PKH or other dyes was used, cell elimination
mediated by the effector cells involving cell membrane
disruption or permeabilization through cytolytic path-
ways such as perforin/granzyme B, resulted in dye leakage
into the medium and artifactual staining of other popula-
tions in the coincubation (15). The use of mAbs does not
pose such a disadvantage due to their specificity for either
effector or target cells.
An additional aspect of using dyes such as PKH-26,
DiO18(3) is the need for cell-labeling prior to initiation of
coincubation (16,17). Although this may not influence the
effector- or target-cell function, this needs to be studied
carefully in every new application of this approach. Again,
this potential risk is not an issue for our approach due to
the addition of mAb at the end of coincubation, just
before AnnV and PI. Since we did not fixate the cells for
mAb staining, surface binding of mAb did not appear to
influence cell functioning or staining with other dyes.
Cell-mediated cytotoxicity is a dynamic process. As
stated earlier, cell-to-cell contact occurs very early during
the course of coincubation and cell-kill reaches a maxi-
mum within 2–4 h. This is one of the potential explana-
tions of the low percentages of conjugated cells observed
in our studies. Target- or effector-cell labeling with fluo-
rescence-conjugated mAb enables identification of a well-
defined population of conjugates. Due to our method’s
lack of the nonspecific labeling complication, several as-
pects of conjugate formation may be studied, including
kinetics (Fig. 1b).
The ability to study cell-mediated cytotoxicity in longer
coincubation times (18 h), in addition to shorter coincu-
bation times (2 h), is another advantage of this method
(15). This appears to be a drawback for CRA as well as for
the methods utilizing PKH-26, PKH-67, or DiO18 due to
increased release of 51Cr and dye leakage, resulting in
staining of the other population. This application is po-
tentially important for studying certain apoptotic path-
ways that take longer to become operational, such as
soluble and membrane-bound TNF--induced apoptosis.
TNF- is expressed by various cytolytic cells both in trans-
membrane and soluble forms. TNF- has been shown to
kill TNF-susceptible targets in 24-h assays (18).
An interesting observation was the correlation between
CRA results and the PC calculated based on the viable
population, which took early apoptotic cell percents into
account as well as the dead/apoptotic (PI) cell percents
(PC-PI). One might assume that CRA results would better-
correlate with the latter approach (PC-PI), since 51Cr is
released from cells that have lost their membrane integ-
rity; however, we were able to show that this was also the
case for the former approach (PC). This correlation indi-
cates that PI may be replaced with a different fluorescent
marker that may help further study of the mechanism of
target cell fate, since the results based on the AnnV stain-
ing pattern are sufficient to calculate PC.
The use of fluorospheres in determining the absolute
number of cells in our method provides an opportunity to
calculate the total cell loss (1,3). Although there was a
very good correlation between PC and CC in short-incu-
bation experiments, in our limited experience this would
not seem to hold true for longer incubation times. Since
the rate of apoptosis and oncosis is known to change at
any given time during the coincubation, utilizing fluoro-
sphere-adjusted counts in calculations reflects the accu-
rate eventual result, expressed as cumulative cytotoxicity
(CC) in this work. Nevertheless, we have observed quite
high target-cell viability percents and low PC, despite high
CC based on fluorosphere-adjusted counts in certain ex-
periments. Use of fluorosphere-adjusted counts in calcu-
lations also proves to be more accurate in experiments
that are associated with very high target-cell kill, such as
high E/T ratio coincubations or in the presence of very
cytotoxic effector cells.
The demonstration of a significant correlation between
effector- and target-cell labeling with fluorescence-conju-
gated mAb emphasizes an important aspect of this ap-
proach, enabling its application to various effector- and
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target-cell types with different cellular characteristics.
Namely, effector-cell staining may be more practical or
appropriate in a setting where target-cell fate needs to be
studied—not just a determination of viability. We have
successfully utilized this method in studying LAK elimina-
tion of acute myeloid leukemia cells from patients (19).
Additionally, we were able to measure mast cell-mediated
killing of myeloid leukemia cells (20). With this method, it
is also possible to carry out experiments on more than one
target cell population in the same tube.
This method can be utilized in investigating cell-medi-
ated cytotoxicity in a variety of different laboratory set-
tings for various purposes. With the advantage of multipa-
rameter flow cytometry, several different variables could
be integrated into the setting, which would enable study
of the mechanisms of death/apoptosis in in vitro cell-
mediated cytotoxicity.
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60 ÖZDEMIR ET AL.
